Triple
T9668356
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Pershing Square Holdings |
E233761
|
entity |
| Predicate | hasSignificantShareholderRoleIn |
P14887
|
FINISHED |
| Object |
Valeant Pharmaceuticals
Valeant Pharmaceuticals was a controversial multinational specialty pharmaceutical company known for aggressive drug price hikes, rapid growth through acquisitions, and subsequent accounting and regulatory scandals.
|
E813059
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Valeant Pharmaceuticals | Statement: [Pershing Square Holdings, hasSignificantShareholderRoleIn, Valeant Pharmaceuticals]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Valeant Pharmaceuticals Context triple: [Pershing Square Holdings, hasSignificantShareholderRoleIn, Valeant Pharmaceuticals]
-
A.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a global pharmaceutical company based in Israel, best known as one of the world’s largest manufacturers of generic medicines and a producer of specialty and over-the-counter drugs.
-
B.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
-
C.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
D.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
E.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Valeant Pharmaceuticals Triple: [Pershing Square Holdings, hasSignificantShareholderRoleIn, Valeant Pharmaceuticals]
Generated description
Valeant Pharmaceuticals was a controversial multinational specialty pharmaceutical company known for aggressive drug price hikes, rapid growth through acquisitions, and subsequent accounting and regulatory scandals.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Valeant Pharmaceuticals Target entity description: Valeant Pharmaceuticals was a controversial multinational specialty pharmaceutical company known for aggressive drug price hikes, rapid growth through acquisitions, and subsequent accounting and regulatory scandals.
-
A.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a global pharmaceutical company based in Israel, best known as one of the world’s largest manufacturers of generic medicines and a producer of specialty and over-the-counter drugs.
-
B.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
-
C.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
D.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
E.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ca848d3b6c8190ae98ea554dea58df |
completed | March 30, 2026, 2:11 p.m. |
| NER | Named-entity recognition | batch_69cd9c3c06e4819080c1b8e66faa482f |
completed | April 1, 2026, 10:29 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d18a208798819088db055e44d288e3 |
completed | April 4, 2026, 10:01 p.m. |
| NEDg | Description generation | batch_69d18ab1239c8190b4a66ccd0db35ffb |
completed | April 4, 2026, 10:03 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69d18b7f7510819083a402d6802c7d95 |
completed | April 4, 2026, 10:06 p.m. |
Created at: March 30, 2026, 8:15 p.m.